Skip to content

Differential analysis of substrate analyses in diagnosing and treating of hypophosphatasia

Differential analysis of substrate analyses in diagnosing and treating of hypophosphatasia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00032058
Enrollment
200
Registered
2023-06-12
Start date
2023-06-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E83.38

Interventions

Group 1: Retrospective data analysis to evaluate the importance of susbtrate analyses in patients with HPP (hypophosphatasia)

Sponsors

Klinische Studieneinheit König Ludwig Haus
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of HPP - genetic variant confirmed

Exclusion criteria

Exclusion criteria: Not confirmed HPP

Design outcomes

Primary

MeasureTime frame
Importance of substrate analyses in patients with HPP

Secondary

MeasureTime frame
Associations with different lab analyses

Countries

Germany

Contacts

Public ContactLothar Seefried

Klinische Studieneinheit König Ludwig Haus

l-seefried.klh@uni-wuerzburg.de00499318033575

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026